Ovid Therapeutics
OVID
#7730
Rank
โ‚ฌ0.37 B
Marketcap
2,01ย โ‚ฌ
Share price
-5.98%
Change (1 day)
64.98%
Change (1 year)

EPS for Ovid Therapeutics (OVID)

EPS in 2026 (TTM): -0,27ย โ‚ฌ

According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,28ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,28ย โ‚ฌ an increase over its 2024 EPS that were of -0,35ย โ‚ฌ.

EPS history for Ovid Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,27ย โ‚ฌ-5.32%
2025-0,28ย โ‚ฌ-18.42%
2024-0,35ย โ‚ฌ
2022-0,70ย โ‚ฌ-143.5%
20211,61ย โ‚ฌ-226.43%
2020-1,28ย โ‚ฌ-11.39%
2019-1,44ย โ‚ฌ-25.47%
2018-1,93ย โ‚ฌ-24.06%
2017-2,54ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 335.48%๐Ÿ‡บ๐Ÿ‡ธ USA